1.
Effect of subconjunctival Bevacizumab injection on the outcome of Ahmed glaucoma valve implantation: a randomized control trial.
Miraftabi Arezoo, Nilforushan Naveed, Darghahi Mina, Alemzadeh Sayyed Amirpooya, Parsamanesh Mohammad, Yadgari Maryam
Clin Exp OphthalmolApr 20187 citationsRandomized Controlled Trial
This study found that adding subconjunctival Bevacizumab to Ahmed Glaucoma Valve implantation significantly improved surgical success rates over one year, suggesting better long-term outcomes for glaucoma patients.